Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;35(8):e14215.
doi: 10.1111/pai.14215.

Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity

Paola Zangari  1 , Carmela Giancotta  1 , Lucia Pacillo  1 , Nicole Colantoni  2 , Fabrizio Leone  2 , Donato Amodio  1   2 , Veronica Santilli  1 , Emma Concetta Manno  1 , Nicola Cotugno  1   2 , Beatrice Rivalta  1 , Gioacchino Andrea Rotulo  1 , Silvia Di Cesare  2 , Andrea Diociaiuti  3 , May El Hachem  3 , Caterina Cancrini  1   2 , Andrea Finocchi  1   2 , Paolo Palma  1   2
Affiliations

Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity

Paola Zangari et al. Pediatr Allergy Immunol. 2024 Aug.
No abstract available

Keywords: atopic dermatitis; biologics; dupilumab; inborn errors of immunity.

PubMed Disclaimer

References

REFERENCES

    1. Tangye SG, Al‐Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42:1‐35.
    1. Vaseghi‐Shanjani M, Smith KL, Sara RJ, et al. Inborn errors of immunity manifesting as atopic disorders. J Allergy Clin Immunol. 2021;148:1130‐1139.
    1. Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21:21‐40.
    1. Giancotta C, Colantoni N, Pacillo L, et al. Tailored treatments in inborn errors of immunity associated with atopy (IEIs‐A) with skin involvement. Front Pediatr. 2023;11:1129249.
    1. European Medicines Agency (EMA). https://www.ema.europa.eu/en/medicines/human/EPAR. Last updated: 23/03/2023. Available from: https://www.ema.europa.eu/en/documents/product‐information/dupixent‐epar....

Substances

Grants and funding

LinkOut - more resources